Park Avenue Securities’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$494K	Buy	+834	New	+$415K	﹤0.01%	1112
2025 Q4	–	Sell	-984	Closed	-$412K	–	1693
2025 Q3	$412K	Sell	984 -1,369	-58%	-$460K	﹤0.01%	1285
2025 Q2	$676K	Buy	2,353 +39	+2%	+$11.7K	0.01%	934
2025 Q1	$713K	Sell	2,314 -300	-11%	-$103K	0.01%	727
2024 Q4	$922K	Buy	2,614 +407	+18%	+$150K	0.01%	807
2024 Q3	$791K	Buy	2,207 +170	+8%	+$57.4K	0.01%	780
2024 Q2	$649K	Buy	2,037 +475	+30%	+$126K	0.01%	843
2024 Q1	$359K	Buy	1,562 +155	+11%	+$35K	﹤0.01%	1100
2023 Q4	$309K	Buy	1,407 +66	+5%	+$15.2K	﹤0.01%	1116
2023 Q3	$303K	Buy	+1,341	New	+$309K	﹤0.01%	1045
2023 Q1	–	Sell	-1,116	Closed	-$310K	–	1145
2022 Q4	$310K	Buy	+1,116	New	+$282K	0.01%	969